Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Spearmint wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
Shared outcomes (1)
Outcomes where both Raloxifene (Evista) and Spearmint have evidence — compare verdict strength side-by-side.
Approved (postmenopausal women) / off-label (male) — clinician-directed. For osteoporosis treatment/prevention and breast-cancer risk reduction the standard, validated dose is 60 mg once daily (the MORE, CORE, RUTH and STAR trials all used 60 mg/day; MORE also tested 120 mg/day with no clear added fracture benefit and more side effects). For off-label male gynecomastia the small published pediatric series used roughly 60 mg/day; there is no FDA-approved male dose and the male evidence is thin and retrospective.
any
Raloxifene hydrochloride 60 mg tablets (approved for postmenopausal osteoporosis and breast-cancer risk reduction)
900 mg/day of standardized spearmint extract (or 2 cups of spearmint herbal tea daily)
Morning with breakfast, Evening with dinner (split dosing mirrors clinical trial protocols)
Standardized aqueous extract (high-rosmarinic acid)
Months to years
Years
Throughout use
Throughout use
2–4 weeks
4–12 weeks
4–8 weeks
8–16 weeks
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
JAMA (1999) · Rct · n=7705
MORE: multicenter, randomized, double-blind, placebo-controlled trial of raloxifene 60 or 120 mg/day in 7,705 postmenopausal women with osteoporosis, followed up to 36 months
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
JAMA (1999) · Rct · n=7705
Pre-specified breast-cancer analysis of the MORE RCT (7,705 postmenopausal women with osteoporosis), followed a median 40 months
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
J Natl Cancer Inst (2004) · Rct · n=5213
CORE: extension of the randomized MORE trial giving 4 additional years of raloxifene 60 mg/day (n=3,510) vs continued placebo (n=1,703)
An evidence-based systematic review of spearmint by the natural standard research collaboration.
Journal of dietary supplements (2010) · Systematic review
Spearmint (Mentha spicata) has demonstrated anti-androgenic, antimicrobial, and antioxidant properties in available literature.
A systematic review of the efficacy of alternative medicine in the treatment of nausea and vomiting of pregnancy.
Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology (2020) · Systematic review
Spearmint syrup was identified as one of several herbal alternatives showing efficacy for mild-to-moderate pregnancy nausea and vomiting.
Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial.
Phytotherapy research : PTR (2010) · Rct · n=42
Forty-one of 42 patients completed this 30-day RCT comparing spearmint tea twice daily to placebo herbal tea.
Based on 2 RCTs in women with PCOS/hirsutism. Tea form equivalent to ~400-600mg extract. Effects specific to women; men should avoid chronic high-dose use.
AI-estimated from published studies. Interpret as directional guidance.
Spearmint has a higher evidence score (6.2/10 vs 5.3/10) and wins in 3 of 3 categories.
No known interactions between Raloxifene (Evista) and Spearmint have been documented in our database. However, always consult a healthcare provider before combining supplements.